Public Calendar: February 25, 2018 - March 3, 2018
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date : 02/26/2018 - 02/26/2018
Location : Silver Spring, MD
Subject : FDA's New Comprehensive Plan for Tobacco and Nicotine Regulation
FDA Participant/Group : KELLEY NDUOM; KATHLEEN QUINN; JOSEPHINE TROPEA; CARLYLE MCWILLIAMS; ANNA ABRAM; DAVID MARKERT; LAUREN SILVIS; AMANDA SUTARIA; MITCHELL ZELLER; RICHARD TURMAN; MICHELE MITAL;
Non FDA Participant/Group : Joseph P. Fragnito (R.J. Reynolds Tobacco Company); James Figlar, Michael Ogden, Mitch Neuhauser, Rich Haselwood (Reynolds American Incorporated);
Event Date : 02/27/2018 - 02/27/2018
Location : Silver Spring, MD
Subject : FDA's New Comprehensive Plan for Tobacco and Nicotine Regulation
FDA Participant/Group : MICHELE MITAL; ANNA ABRAM; RICHARD TURMAN; CARLYLE MCWILLIAMS; JOSEPHINE TROPEA; MITCHELL ZELLER; KATHLEEN QUINN; LAUREN SILVIS; JENNIFER CARUSO;
Non FDA Participant/Group : Carlos Fuente, Jorge Padron, Robert Levin, Rocky Patel (Cigar Rights of America); Craig Cass, Daniel Trope, Greg Zimmerman (International Premium Cigar & Pipe Retailers Association); Will Woodlee (Kleinfeld, Kaplan & Becker); Dennis Potter (K & L Gates LLP);
Event Date : 02/28/2018 - 02/28/2018
Location : Silver Spring, MD
Subject : Public Meeting: Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act
FDA Participant/Group : Several FDA staff participants
Non FDA Participant/Group : Supply chain stakeholders (manufacturers, wholesalers, dispensers, solution providers, consultants, government employees and other registered individuals);
Event Date : 03/01/2018 - 03/01/2018
Location : Washington, DC
Subject : Combating the Opioid Crisis: From Communities to the Capital
FDA Participant/Group : JENNIFER RODRIGUEZ;
Non FDA Participant/Group : Federal, state, and local government agencies, media, academia, industry, and medical professionals
Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
Event Date : 02/27/2018
Location : Covington, KY
Subject : The Produce Safety Alliance Water Summit: Food Safety Modernization Act (FSMA) Produce Safety Rule
FDA Participant/Group : N/A
Non FDA Participant/Group : Several members (Produce Safety Alliance);
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jennifer Rodriguez, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name : RADM Denise Hinton , Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 02/26/2018 - 02/27/2018
Location : Austin, Texas
Subject : International Conference on Drug Development: CDER Perspective: 21st Century Cures Act and PDUFA VI
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date : 03/01/2018 - 03/01/2018
Location : Bethesda, MD
Subject : Rare Disease Day Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 02/26/2018 - 02/26/2018
Location : Washington, DC
Subject : National Evaluation System for Health Technology Coordinating Center: Governing Committee Meeting
FDA Participant/Group : DOUGLAS DUMONT; JOSHUA CHETTA; DANIEL CANOS; GREGORY PAPPAS;
Non FDA Participant/Group : Rachael Fleurence, Rachel Rath, Tiffany Abushaikha and Nirav Dalal (Medical Device Innovation Consortium);
Event Date : 03/01/2018 - 03/01/2018
Location : Washington, DC
Subject : Advance Medical Technology Association Senior Regulatory Group Meeting: CDRH 2018 Priorities
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Rebecca K. Wood, J.D., Chief Counsel
No Significant Event